Brazilian digital prescription platform Mevo raised $18M in a funding round led by Prosus. Matrix, Jefferson River Capital, and Floating Point also participated in the round. The round follows Mevo’s Series B in 2024.
Founded in 2017, Mevo connects doctors, patients, pharmacies, and pharmaceutical companies through its digital prescription platform. Mevo has expanded its product to include exam scheduling and online medication fulfillment, building a broader healthcare ecosystem.
With the funds, Mevo will expand exam scheduling, integrate patient support programs, and grow its online pharmacy operations.
Mevo is integrated with more than 1,100 healthcare institutions and seven major health insurance providers, reaching about 30% of Brazil’s private healthcare market. Mevo Shop, the company’s pharmacy vertical, connects with more than 11 pharmacy chains and about 1,600 retail locations.
Read more on Prosus